Overexpression of Bcl-xL may counteract apoptosis induced by the envelope protein of SARS-CoV, while downregulation of Bcl-xL may be a molecular event leading to the development of viral pathogenesis, such as HIV-driven immune impairment or HCV-associated liver disease. The gene discussed is BCL2L1; the disease is liver disorder.